NDC 85237-1829-0 - Alka-Seltzer Original
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-1829
- Requested NDC
- 85237-1829-0
- Package NDCs from labels
- 85237-1829-1, 85237-1829-0, 85237-1829-2, 85237-1829-3, 85237-1829-4, 85237-1829-6, 85237-1829-7
- Manufacturer
- Select Consumer Group
- Effective date
- 2026-05-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alka-Seltzer Original - Select Consumer Group | Select Consumer Group | 2026-05-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85237-1829-1 | Alka-Seltzer Original | 1 in 1 BLISTER PACK | TABLET, EFFERVESCENT | 1 | 1 | |
| 85237-1829-1 | Alka-Seltzer Original | 2 in 1 POUCH | TABLET, EFFERVESCENT | 2 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate | SODIUM BICARBONATE | A-S Medication Solutions | 619cb558-84e5-43ea-91e9-28c764f9f9c0 | 2023-06-21 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 7a2d8dab-750f-43c1-933c-4169a840c60c | 2023-06-20 | Warnings, Adverse reactions | 8MDF5V39QO |
| LY-CO | ANGELICA ARCHANGELICA, KALI MURIATICUM, YUCCA FILAMENTOSA, CARTILAGO SUIS, PHYTOLACCA DECANDRA, HYDRASTIS CANADENSIS, RHUS TOX, CAUSTICUM, MAGNESIA PHOSPHORICA, MANGANUM METALLICUM, OXALICUM ACIDUM, ARNICA MONTANA, BORRELIA BURGDORFERI NOSODE, LATRODECTUS MACTANS, CITRICUM ACIDUM, CYTOMEGALOVIRUS NOSODE, RICKETTSIA NOSODE (RICKETTSIA PROWAZEKII), CHLAMYDIA TRACHOMATIS, LEDUM PALUSTRE | Bhp Holdings, Inc. | 47140966-5b49-432d-bf35-bcae14f42082 | 2023-06-01 | Warnings | XF417D3PSL |
| Lyme and Co-Infection Nosode | ANGELICA ARCHANGELICA, KALI MURIATICUM, YUCCA FILAMENTOSA, CARTILAGO SUIS, PHYTOLACCA DECANDRA, HYDRASTIS CANADENSIS, RHUS TOX, CAUSTICUM, MAGNESIA PHOSPHORICA, MANGANUM METALLICUM, OXALICUM ACIDUM, ARNICA MONTANA, BABESIA MICROTI, BORRELIA BURGDORFERI NOSODE, LATRODECTUS MACTANS, CITRICUM ACIDUM, CYTOMEGALOVIRUS NOSODE, RICKETTSIA NOSODE (RICKETTSIA PROWAZEKII), CHLAMYDIA TRACHOMATIS, LEDUM PALUSTRE | Bhp Holdings, Inc. | f6186157-256f-4454-b122-f7665e3286f4 | 2023-06-01 | Warnings | XF417D3PSL |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | b620938d-ab2d-0934-e053-2a95a90a8483 | 2023-05-23 | Warnings, Adverse reactions | 8MDF5V39QO |
| ACETAMINOPHEN ASPIRIN AND CAFFEINE | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Aurohealth LLC | e47e2169-4b31-4c23-bb9d-c26aa106ea37 | 2023-05-11 | Warnings | R16CO5Y76E |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | AAA PHARMACEUTICAL, INC. | f9c9a0b4-dbfe-7da9-e053-6294a90a7e09 | 2023-05-03 | Warnings | R16CO5Y76E |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | d1636b56-ad83-4439-e053-2a95a90a135e | 2023-05-02 | Warnings, Adverse reactions | 8MDF5V39QO |
| DG Health migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Dolgencorp, LLC | d0e82cac-dfbb-49cb-99c8-560b02fb1a8c | 2023-04-05 | Warnings | R16CO5Y76E |
| basic care migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Amazon.com Services LLC | edcc7b4b-1317-4060-b947-8c16effc5742 | 2023-02-27 | Warnings | R16CO5Y76E |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | XF417D3PSL |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Aspirin Enteric Coated | ASPIRIN 81 MG | Lodaat LLC | 04017bc9-602a-4204-96a9-b7f9713155f6 | 2023-01-31 | Warnings | M013 R16CO5Y76E |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | FSA STORE INC. | ec6b7017-cf12-09a7-e053-2995a90a2db9 | 2023-01-12 | Warnings | R16CO5Y76E |
| CitriPlus | JUGLANS REGIA WHOLE AND ANHYDROUS CITRIC ACID | PEKANA Natuheilmittel GmbH | 11db1b5b-2959-42c4-a059-25c951933004 | 2023-01-11 | Warnings | XF417D3PSL |
| Glucoreg | ASCORBICUM ACIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, DHEA (DEHYDROEPIANDROSTERONE), PHLORIDZINUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, ACETALDEHYDE, INSULINUM (SUIS), INSULINUM (HUMAN), HEPAR SUIS, PANCREAS SUIS, PHLORIDZINUM, BARYTA OXALICA, ALLOXANUM, BERBERIS VULGARIS, CARCINOSIN, LYCOPODIUM CLAVATUM, MOMORDICA BALSAMINA, PHOSPHORICUM ACIDUM, PHOSPHORUS, | Deseret Biologicals, Inc. | 5117f980-95b8-4fc8-9425-8f6f05639437 | 2022-12-29 | Warnings | XF417D3PSL |
| Omeprazole, Sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Guardian Drug Company | e5c6c2cf-fb3b-456a-a0a0-be396d6f8319 | 2022-11-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | XF417D3PSL | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.